Page last updated: 2024-08-16

tibolone and Activated Protein C Resistance

tibolone has been researched along with Activated Protein C Resistance in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dahm, AEA; Eilertsen, AL; Høibraaten, E; Lofthus, CM; Mowinckel, MC; Sandset, PM	1
Eilertsen, AL; Hemker, HC; Liestøl, S; Mowinckel, MC; Sandset, PM	1

Trials

2 trial(s) available for tibolone and Activated Protein C Resistance

Article	Year
Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2019, Volume: 30, Issue:1 Topics: Activated Protein C Resistance; Blood Coagulation; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Sex Hormone-Binding Globulin; Venous Thrombosis	2019
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system. Thrombosis and haemostasis, 2007, Volume: 97, Issue:6 Topics: Activated Protein C Resistance; Administration, Oral; Blood Coagulation; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Protein C; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tablets; Thromboembolism; Treatment Outcome; Venous Thrombosis	2007

Article

Year

Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2019, Volume: 30, Issue:1

Topics: Activated Protein C Resistance; Blood Coagulation; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Sex Hormone-Binding Globulin; Venous Thrombosis

2019

Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.

Thrombosis and haemostasis, 2007, Volume: 97, Issue:6

Topics: Activated Protein C Resistance; Administration, Oral; Blood Coagulation; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Protein C; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tablets; Thromboembolism; Treatment Outcome; Venous Thrombosis

2007